Dysregulation of serotonergic signaling, particularly through 5-HT receptor subtypes and altered SERT expression, contributes to abnormal motility and visceral hypersensitivity across IBS subtypes. The gene discussed is SLC6A4; the disease is irritable bowel syndrome.